Neurodegenerative Disease & Obesity

Neurodegenerative disorders and obesity appear to have common pathologies including neuroinflammation. Targeting common pathways may prove to be a useful treatment strategy for neurodegenerative disease. Discover the latest research on neurodegenerative disorders and obesity here.

January 16, 2022

Critical changes in hypothalamic gene networks in response to pancreatic cancer as found by single-cell RNA sequencing.

Molecular Metabolism
Christian HuismanDaniel L Marks
January 14, 2022

The Spectrum of Genetic Variants Associated with the Development of Monogenic Obesity in Qatar.

Obesity Facts
Nadien AbouHashemMashael Al-Shafai
January 14, 2022

Kisspeptin and the Genetic Obesity Interactome.

Advances in Experimental Medicine and Biology
Geronikolou SGeorge P Chrousos
January 12, 2022
Review
Open Access

Anorexigenic Effects of Intermittent Hypoxia on the Gut-Brain Axis in Sleep Apnea Syndrome.

International Journal of Molecular Sciences
Ryogo ShobatakeShin Takasawa
January 12, 2022
Open Access

Divergent Effect of Central Incretin Receptors Inhibition in a Rat Model of Sporadic Alzheimer's Disease.

International Journal of Molecular Sciences
Jelena Osmanovic BarilarMelita Salkovic-Petrisic
January 12, 2022
Review
Open Access

The Role of Glial Cells in Regulating Feeding Behavior: Potential Relevance to Anorexia Nervosa.

Journal of Clinical Medicine
Linda FrintropMarkus Kipp
January 10, 2022
Review

Preventive and Therapeutic aspects of Fermented Foods.

Journal of Applied Microbiology
Rwivoo BaruahPrakash M Halami
January 11, 2022
Open Access

Liraglutide Improves Cognitive and Neuronal Function in 3-NP Rat Model of Huntington's Disease.

Frontiers in Pharmacology
Samar M ShawkiHanan S El-Abhar
January 7, 2022
Open Access

Neddylation-dependent protein degradation is a nexus between synaptic insulin resistance, neuroinflammation and Alzheimer's disease.

Translational Neurodegeneration
Alessandro Dario ConfetturaMichael R Kreutz
January 7, 2022
Open Access

Fibroblast Growth Factor-1 Activates Neurons in the Arcuate Nucleus and Dorsal Vagal Complex.

Frontiers in Endocrinology
Brandon L RobertsPaul Kievit
January 7, 2022

The Effect of Sleep Deprivation and Subsequent Recovery Period on the Synaptic Proteome of Rat Cerebral Cortex.

Molecular Neurobiology
Péter GulyássyKatalin Adrienna Kékesi
January 6, 2022

Liraglutide attenuate central nervous inflammation and demyelination through AMPK and pyroptosis-related NLRP3 pathway.

CNS Neuroscience & Therapeutics
Shuang SongBin Li
January 3, 2022
Open Access

Sex Differences in Metabolic Recuperation After Weight Loss in High Fat Diet-Induced Obese Mice.

Frontiers in Endocrinology
Santiago Guerra-CanteraJulie A Chowen
January 3, 2022
Open Access

Soluble Epoxide Hydrolase Deletion Limits High-Fat Diet-Induced Inflammation.

Frontiers in Pharmacology
Karen M WagnerBruce D Hammock
January 3, 2022
Review

New therapeutic horizons for plasma phospholipid transfer protein (PLTP): Targeting endotoxemia, infection and sepsis.

Pharmacology & Therapeutics
Thomas GautierLaurent Lagrost

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2022 Meta ULC. All rights reserved
/feed-previews/neurodegenerative-disease-obesity/ccba503d-8bb5-4c94-98cf-60e8e607c60d